Urgent action is needed to safeguard the future of Egypt’s pharmaceutical industry, a specialist has warned.
Ahmed Galal, a leading figure in the industry, told Arab News the pharmaceutical sector faces significant challenges adapting to the global market, as well as “aligning with modern technology to deliver effective medicine at an affordable price.”
His comments came after a parliamentary session on Saturday in which MPs discussed a specialist report outlining a strategy to “future-proof” the pharmaceutical industry.
The report urged the government to adopt new financing policies for the sector, warning that current exchange rate fluctuations are hindering the industry, particularly small and medium-sized companies.
“National drug security and the well-being of the Egyptian patient are most affected in the event of the pharmaceutical industry’s collapse,” Galal said.
“Urgent action is needed to preserve this industry. This should be a priority and must be supported by every patriotic Egyptian,” he added.
“Drug consumption in Egypt has seen a significant rise recently due to the increasing population numbers, improved health awareness, and development of health care programs. While the pharmaceutical industry in Egypt is among the most successful, its primary market is local due to its focus on producing traditional medicines. These lack innovative elements that could secure a place in the new global market.”